{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:00:23Z","timestamp":1790784023349,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T00:00:00Z","timestamp":1663459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Angiotensin II is one of the vasopressors available for use in septic shock. However, its effects on the septic myocardium remain unclear. The aim of the study was to compare the effects of angiotensin II and norepinephrine on cardiac function and myocardial oxygen consumption, inflammation and injury in experimental septic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This randomized, open-label, controlled study was performed in 20 anesthetized and mechanically ventilated pigs. Septic shock was induced by fecal peritonitis in 16 animals, and four pigs served as shams. Resuscitation with fluids, antimicrobial therapy and abdominal drainage was initiated one hour after the onset of septic shock. Septic pigs were randomly allocated to receive one of the two drugs to maintain mean arterial pressure between 65 and 75\u00a0mmHg for 8\u00a0h.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were no differences in MAP, cardiac output, heart rate, fluid balance or tissue perfusion indices in the two treatment groups but myocardial oxygen consumption was greater in the norepinephrine-treated animals. Myocardial mRNA expression of interleukin-6, interleukin-6 receptor, interleukin-1 alpha, and interleukin-1 beta was higher in the norepinephrine than in the angiotensin II group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In septic shock, angiotensin II administration is associated with a similar level of cardiovascular resuscitation and less myocardial oxygen consumption, and inflammation compared to norepinephrine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-04161-3","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T01:02:25Z","timestamp":1663462945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock"],"prefix":"10.1186","volume":"26","author":[{"given":"Bruno","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuhong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dewachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Favory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Khaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Moiroux-Sahraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Annoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Vasques-N\u00f3voa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Rocha-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Roberto","family":"Roncon-Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Hubesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassane","family":"Njimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio S.","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Creteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Herpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,18]]},"reference":[{"key":"4161_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"J-L Vincent","year":"2019","unstructured":"Vincent J-L, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23:196.","journal-title":"Crit Care"},{"key":"4161_CR2","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;Publish Ahead of Print."},{"key":"4161_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/SHK.0000000000000579","volume":"46","author":"A Beurton","year":"2016","unstructured":"Beurton A, Ducrocq N, Auchet T, Joineau-Groubatch F, Falanga A, Kimmoun A, et al. Beneficial effects of norepinephrine alone on cardiovascular function and tissue oxygenation in a pig model of cardiogenic shock. Shock. 2016;46:214\u20138.","journal-title":"Shock"},{"key":"4161_CR4","doi-asserted-by":"publisher","first-page":"S508","DOI":"10.1097\/01.CCM.0000278047.06965.20","volume":"35","author":"E Barth","year":"2007","unstructured":"Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, et al. Glucose metabolism and catecholamines. Crit Care Med. 2007;35:S508\u201318.","journal-title":"Crit Care Med"},{"key":"4161_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","volume":"202","author":"R Stolk","year":"2020","unstructured":"Stolk R, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden T, et al. Norepinephrine dysregulates the immune response and compromises host defense during sepsis. Am J Resp Crit Care. 2020;202:830\u201342.","journal-title":"Am J Resp Crit Care"},{"key":"4161_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18:1\u201311.","journal-title":"Nat Rev Cardiol"},{"key":"4161_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ncpcardio1066","volume":"5","author":"AR Lyon","year":"2008","unstructured":"Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE. Stress (Takotsubo) cardiomyopathy\u2014a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Card. 2008;5:22\u20139.","journal-title":"Nat Clin Pract Card"},{"key":"4161_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13613-021-00869-7","volume":"11","author":"M Carrara","year":"2021","unstructured":"Carrara M, Ferrario M, Pinto BB, Herpain A. The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review. Ann Intensive Care. 2021;11:80.","journal-title":"Ann Intensive Care"},{"key":"4161_CR9","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1097\/CCM.0000000000000436","volume":"42","author":"P Asfar","year":"2014","unstructured":"Asfar P, Chawla L, Lerolle N, Radermacher P. Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*. Crit Care Med. 2014;42:1961\u20133.","journal-title":"Crit Care Med"},{"key":"4161_CR10","first-page":"139","volume":"11","author":"A Kimmoun","year":"2013","unstructured":"Kimmoun A, Ducrocq N, Levy B. Mechanisms of vascular hyporesponsiveness in septic shock. Curr Vasc Pharmacol. 2013;11:139\u201349.","journal-title":"Curr Vasc Pharmacol"},{"key":"4161_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13054-018-1967-3","volume":"22","author":"B Levy","year":"2018","unstructured":"Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care Lond Engl. 2018;22:52.","journal-title":"Crit Care Lond Engl"},{"key":"4161_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/NEJMoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. New Engl J Med. 2017;377:419\u201330.","journal-title":"New Engl J Med"},{"key":"4161_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","volume":"202","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, et al. Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Resp Crit Care. 2020;202:1253\u201361.","journal-title":"Am J Resp Crit Care."},{"key":"4161_CR14","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","volume":"96","author":"KT Weber","year":"1997","unstructured":"Weber KT. Extracellular matrix remodeling in heart failure: a role for De Novo angiotensin II generation. Circulation. 1997;96:4065\u201382.","journal-title":"Circulation"},{"key":"4161_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1139\/cjpp-2018-0592","volume":"97","author":"D Jacques","year":"2019","unstructured":"Jacques D, Provost C, Normand A, Abdallah NA, Al-Khoury J, Bkaily G. Angiotensin II induces apoptosis of human right and left ventricular endocardial endothelial cells by activating the AT2 receptor1. Can J Physiol Pharm. 2019;97:581\u20138.","journal-title":"Can J Physiol Pharm"},{"key":"4161_CR16","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-97.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4161_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13054-018-2006-0","volume":"22","author":"N Buchtele","year":"2018","unstructured":"Buchtele N, Schwameis M, Jilma B. Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe? Crit Care. 2018;22:96.","journal-title":"Crit Care"},{"key":"4161_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/SHK.0000000000000807","volume":"47","author":"E Antonucci","year":"2017","unstructured":"Antonucci E, Gleeson PJ, Annoni F, Agosta S, Orlando S, Taccone FS, et al. Angiotensin II in refractory septic shock. Shock. 2017;47:560\u20136.","journal-title":"Shock"},{"key":"4161_CR19","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1161\/01.CIR.92.9.2683","volume":"92","author":"U Ikeda","year":"1995","unstructured":"Ikeda U, Maeda Y, Kawahara Y, Yokoyama M, Shimada K. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation. 1995;92:2683\u20139.","journal-title":"Circulation"},{"key":"4161_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/SHK.0000000000001212","volume":"50","author":"MF Osuchowski","year":"2018","unstructured":"Osuchowski MF, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon J-M, et al. Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS). Shock. 2018;50:377\u201380.","journal-title":"Shock"},{"key":"4161_CR21","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"NP du Sert","year":"2020","unstructured":"du Sert NP, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Plos Biol. 2020;18:e3000410.","journal-title":"Plos Biol"},{"key":"4161_CR22","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1109\/TBME.2019.2894333","volume":"66","author":"M Carrara","year":"2018","unstructured":"Carrara M, Herpain A, Baselli G, Ferrario M. A mathematical model of dPdt max for the evaluation of the dynamic control of heart contractility in septic shock. IEEE Trans Bio-Med Eng. 2018;66:2719\u201327.","journal-title":"IEEE Trans Bio-Med Eng"},{"key":"4161_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fphys.2020.00594","volume":"11","author":"M Carrara","year":"2020","unstructured":"Carrara M, Herpain A, Baselli G, Ferrario M. Vascular decoupling in septic shock: the combined role of autonomic nervous system, arterial stiffness, and peripheral vascular tone. Front Physiol. 2020;11:594.","journal-title":"Front Physiol"},{"key":"4161_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1164\/rccm.201801-0088CI","volume":"199","author":"J-L Teboul","year":"2019","unstructured":"Teboul J-L, Monnet X, Chemla D, Michard F. Arterial pulse pressure variation with mechanical ventilation. Am J Resp Crit Care. 2019;199:22\u201331.","journal-title":"Am J Resp Crit Care"},{"key":"4161_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1007\/s00134-013-2906-z","volume":"39","author":"AW Kirkpatrick","year":"2013","unstructured":"Kirkpatrick AW, Roberts DJ, Waele JD, Jaeschke R, Malbrain MLNG, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intens Care Med. 2013;39:1190\u2013206.","journal-title":"Intens Care Med"},{"key":"4161_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.79.4.840","volume":"79","author":"RD Bernstein","year":"1996","unstructured":"Bernstein RD, Ochoa FY, Xu X, Forfia P, Shen W, Thompson CI, et al. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 1996;79:840\u20138.","journal-title":"Circ Res"},{"key":"4161_CR27","doi-asserted-by":"publisher","first-page":"H696","DOI":"10.1152\/ajpheart.00398.2001","volume":"282","author":"S Setty","year":"2002","unstructured":"Setty S, Tune JD, Downey HF. Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion. Am J Physiol Heart C. 2002;282:H696-703.","journal-title":"Am J Physiol Heart C"},{"key":"4161_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/01.CIR.76.6.1422","volume":"76","author":"DA Kass","year":"2018","unstructured":"Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K. Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships. Circulation. 2018;76:1422\u201336.","journal-title":"Circulation"},{"key":"4161_CR29","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/01.CIR.82.6.1973","volume":"82","author":"CS Moravec","year":"2018","unstructured":"Moravec CS, Schluchter MD, Paranandi L, Czerska B, Stewart RW, Rosenkranz E, et al. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 2018;82:1973\u201384.","journal-title":"Circulation"},{"key":"4161_CR30","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1073\/pnas.0607583103","volume":"103","author":"K Rajagopal","year":"2006","unstructured":"Rajagopal K, Whalen EJ, Violin JD, Stiber JA, Rosenberg PB, Premont RT, et al. \u03b2-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes. Proc Natl Acad Sci. 2006;103:16284\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"4161_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-201X.2004.01341.x","volume":"182","author":"M Broom\u00e9","year":"2004","unstructured":"Broom\u00e9 M, Haney M, H\u00e4ggmark S, Johansson G, \u00c5neman A, Biber B. Pressure-independent cardiac effects of angiotensin II in pigs. Acta Physiol Scand. 2004;182:111\u20139.","journal-title":"Acta Physiol Scand"},{"key":"4161_CR32","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","volume":"42","author":"TD Corr\u00eaa","year":"2014","unstructured":"Corr\u00eaa TD, Jeger V, Pereira AJ, Takala J, Djafarzadeh S, Jakob SM. Angiotensin II in septic shock. Crit Care Med. 2014;42:e550\u20139.","journal-title":"Crit Care Med"},{"key":"4161_CR33","doi-asserted-by":"publisher","first-page":"R190","DOI":"10.1186\/cc8185","volume":"13","author":"L Wan","year":"2009","unstructured":"Wan L, Langenberg C, Bellomo R, May CN. Angiotensin II in experimental hyperdynamic sepsis. Crit Care Lond Engl. 2009;13:R190.","journal-title":"Crit Care Lond Engl"},{"key":"4161_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.chest.2018.09.032","volume":"155","author":"D Orso","year":"2019","unstructured":"Orso D, Copetti R. Adrenergic overstimulation A neglected mechanism of sepsis-related cardiomyopathy. Chest. 2019;155:647.","journal-title":"Chest"},{"key":"4161_CR35","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.00206.2014","volume":"308","author":"K Narumi","year":"2015","unstructured":"Narumi K, Hirose T, Sato E, Mori T, Kisu K, Ishikawa M, et al. A functional (pro)renin receptor is expressed in human lymphocytes and monocytes. Am J Physiol Renal. 2015;308:F487\u201399.","journal-title":"Am J Physiol Renal"},{"key":"4161_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jss.2013.08.004","volume":"186","author":"Y Hirano","year":"2014","unstructured":"Hirano Y, Takeuchi H, Suda K, Hagiwara T, Miyasho T, Kawamura Y, et al. (Pro)renin receptor blocker improves survival of rats with sepsis. J Surg Res. 2014;186:269\u201377.","journal-title":"J Surg Res"},{"key":"4161_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","volume":"38","author":"M Bucher","year":"2001","unstructured":"Bucher M, Ittner K-P, Hobbhahn J, Taeger K, Kurtz A. Downregulation of angiotensin II type 1 receptors during sepsis. Hypertension. 2001;38:177\u201382.","journal-title":"Hypertension"},{"key":"4161_CR38","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","volume":"118","author":"E Kaschina","year":"2008","unstructured":"Kaschina E, Grzesiak A, Li J, Foryst-Ludwig A, Timm M, Rompe F, et al. Angiotensin II type 2 receptor stimulation. Circulation. 2008;118:2523\u201332.","journal-title":"Circulation"},{"key":"4161_CR39","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1097\/CCM.0000000000003296","volume":"46","author":"F Vasques-N\u00f3voa","year":"2018","unstructured":"Vasques-N\u00f3voa F, Laundos TL, Cerqueira RJ, Quina-Rodrigues C, Soares-dos-Reis R, Baganha F, et al. MicroRNA-155 amplifies nitric oxide & sol; cGMP signaling and impairs vascular angiotensin II reactivity in septic shock. Crit Care Med. 2018;46:e945\u201354.","journal-title":"Crit Care Med"},{"key":"4161_CR40","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1164\/rccm.202012-4461OC","volume":"204","author":"L Gerard","year":"2021","unstructured":"Gerard L, Lecocq M, Bouzin C, Hoton D, Schmit G, Pereira JP, et al. Increased angiotensin-converting enzyme 2 and loss of alveolar type II cells in COVID-19-related acute respiratory distress syndrome. Am J Resp Crit Care. 2021;204:1024\u201334.","journal-title":"Am J Resp Crit Care"},{"key":"4161_CR41","doi-asserted-by":"crossref","unstructured":"Picod A, Deniau B, Ayar PV, Genest M, Julian N, Azibani F, et al. Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3. Am J Resp Crit Care. 2020.","DOI":"10.1164\/rccm.202010-3873LE"},{"key":"4161_CR42","doi-asserted-by":"crossref","unstructured":"Chawla LS, Bellomo R. Reply to: Alteration of the renin-angiotensin-aldosterone system in shock: role of the dipeptidyl peptidase 3. Am J Resp Crit Care. 2020.","DOI":"10.1164\/rccm.202010-3968LE"},{"key":"4161_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fmed.2019.00107","volume":"6","author":"J Schleifenbaum","year":"2019","unstructured":"Schleifenbaum J. Alamandine and its receptor MrgD pair up to join the protective arm of the renin-angiotensin system. Front Med. 2019;6:107.","journal-title":"Front Med"},{"key":"4161_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.202103-0613OC","volume":"204","author":"MA Garcia","year":"2021","unstructured":"Garcia MA, Rucci JM, Thai KK, Lu Y, Kipnis P, Go AS, et al. Association between troponin I levels during sepsis and postsepsis cardiovascular complications. Am J Resp Crit Care. 2021;204:557\u201365.","journal-title":"Am J Resp Crit Care"},{"key":"4161_CR45","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1042\/CS20160243","volume":"130","author":"BSM Chow","year":"2016","unstructured":"Chow BSM, Allen TJ. Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease. Clin Sci. 2016;130:1307\u201326.","journal-title":"Clin Sci"},{"key":"4161_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13613-019-0543-6","volume":"9","author":"A Guillon","year":"2019","unstructured":"Guillon A, Preau S, Aboab J, Azabou E, Jung B, et al. Preclinical septic shock research: why we need an animal ICU. Ann Intensive Care. 2019;9:66.","journal-title":"Ann Intensive Care"},{"key":"4161_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/SHK.0000000000001209","volume":"51","author":"J Hellman","year":"2019","unstructured":"Hellman J, Bahrami S, Boros M, Chaudry IH, Fritsch G, Gozdzik W, et al. Part III: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for fluid resuscitation and antimicrobial therapy endpoints. Shock Augusta Ga. 2019;51:33\u201343.","journal-title":"Shock Augusta Ga"},{"key":"4161_CR48","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/cc7959","volume":"13","author":"F Simon","year":"2009","unstructured":"Simon F, Giudici R, Scheuerle A, Gr\u00f6ger M, Asfar P, Vogt JA, et al. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care. 2009;13:R113.","journal-title":"Crit Care"},{"key":"4161_CR49","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/cc6197","volume":"11","author":"V Krejci","year":"2007","unstructured":"Krejci V, Hiltebrand LB, Jakob SM, Takala J, Sigurdsson GH. Vasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow. Crit Care. 2007;11:R129\u2013R129.","journal-title":"Crit Care"},{"key":"4161_CR50","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1097\/CCM.0b013e31825b916b","volume":"40","author":"TD Corr\u00eaa","year":"2012","unstructured":"Corr\u00eaa TD, Vuda M, Blaser AR, Takala J, Djafarzadeh S, D\u00fcnser MW, et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med. 2012;40:2841\u20139.","journal-title":"Crit Care Med"},{"key":"4161_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"4161_CR52","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s001340050768","volume":"24","author":"G Bernardin","year":"1998","unstructured":"Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S. \u03b2-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intens Care Med. 1998;24:1315\u201322.","journal-title":"Intens Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04161-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04161-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04161-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T02:02:36Z","timestamp":1663466556000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04161-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4161"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04161-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,18]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local animal ethics committee (Comit\u00e9 Ethique du Bien-\u00catre Animal; protocol number 724N) from the Universit\u00e9 Libre de Bruxelles in Brussels (Belgium). Experiments were performed in the Experimental Laboratory of Intensive Care of the ULB (LA1230406).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}